We can buy this stock at 0,38$, Idera Pharmaceuticals Inc, with address at 505 EAGLEVIEW BOULEVARD SUITE 212, EXTON, Pennsylvania, 19341, United States, is a publicly traded company and its visible heads at the moment are Daniel B. Soland (Chief Operating Officer & Senior Vice President), John J. Kirby (Chief Financial Officer & Senior Vice President), Vincent J. Milano (President, Chief Executive Officer & Director). Focused on Biotechnology: Biological Products (No Diagnostic Substances) was created long ago in United States.
The closing price of the stock yesterday was desconocido$.
The current range on the same day is from 0,38$ - 0,44$, with a percentage difference of 0,41$ quite wide that helps to be able to do day trading.
The company has an annual revenue of desconocido.
The last registered opening is of desconocido.
If we think of formulas to know when to buy or sell a stock, a value that appears in them always comes to mind, which is the range between the lowest and the highest price that the stock has obtained, for example, here it has been between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].
Buscar
